The significant reductions in some major inflammatory markers in the LOW-HIIT group can likely provide benefits of clinical relevance since CRP [89], IL-6 [90], and LBP [91,92] concentrations are closely linked to MetS and associated secondary diseases and health risks. The gene discussed is IL6; the disease is metabolic syndrome.